Pharmacology

Action Mechanism of Action Reference
INHIBITOR Tumor necrosis factor ligand superfamily member 4 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Dermatitis, Atopic 2 D003876 ClinicalTrials
Immune System Diseases 1 D007154 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4594569
FDA SRS YZ6BH6TN8P